Real-time enrollment status for this asthma clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 3:02 AM UTC
| NCT Number | NCT07219173 |
| Recruiting Status | Recruiting |
| Condition | Asthma |
| Phase | PHASE2 |
| Target Enrollment | 531 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | October 8, 2026 (5 days ago) |
As of October 13, 2026: Clinical trial NCT07219173 is currently recruiting participants. This phase2 study for asthma is actively seeking new participants at 17 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07219173 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07219173 was last updated 5 days ago (October 8, 2026). HelloStudys verifies this status automatically.